Successfully licensed helicase-primase inhibitor program for recurrent genital herpes to Gilead, including candidates ABI-5366 and ABI-1179, ...
HerResolve™ first and only assay validated against ground truth of laparoscopy with confirmed histology. Company to ...
DarioHealth Corp. (NASDAQ: DRIO) (the "Company", "DarioHealth" or "Dario"), a leader in global digital health, today ...
LOS ANGELES, CA, UNITED STATES, March 18, 2026 /EINPresswire.com/ -- From January 20 to 27, 2026, the 40th AAAI ...
Chronos- PD shows that biological changes associated with Parkinson's disease (PD) can emerge up to 12 years before clinical diagnosisUncovered reproducible early molecular signals and distinct molecu ...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the randomized Phase 2 FOURLIGHT-1 study evaluating atirmociclib in combination with fulvestrant, versus fulvestrant or everolimus ...
Explore 6 job-ready courses from Great Learning Academy Pro+ in collaboration with Microsoft. Learn Excel, SQL, Power BI, and ...
Treatment with TransCon CNP demonstrated continued improvement in observed change from baseline in upper-to-lower body segment ratio during the second year, from -0.04 at Week 52 to -0.10 at Week 104.
Enara Bio, a pioneer in Dark Antigen® discovery and bispecific T cell engager innovation, today announced new data to be presented at the American Association for Cancer Research (AACR) Annual Meeting ...
Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics” or the "Company”), a clinical-stage immunotherapy company developing pelar ...
Dr. Melissa Ward Jones discusses the strengths of organizing regular project workshops to support project co-production ...
This study was a retrospective observational analysis using the PurpleLab ® CLEAR Claims database, a comprehensive dataset based on medical insurance claims across the United States and was conducted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results